Jump Financial’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-242,017
Closed -$874K 1847
2025
Q4
$874K Buy
242,017
+126,217
+109% +$550K 0.01% 1033
2025
Q3
$437K Buy
+115,800
New +$447K 0.01% 1336
2024
Q3
Sell
-281,000
Closed -$1.87M 1609
2024
Q2
$1.87M Buy
281,000
+194,812
+226% +$1.44M 0.04% 581
2024
Q1
$877K Buy
86,188
+75,528
+709% +$768K 0.02% 873
2023
Q4
$120K Buy
+10,660
New +$44.5K ﹤0.01% 1643
2023
Q3
Sell
-21,249
Closed -$75K 1813
2023
Q2
$75K Sell
21,249
-267,451
-93% -$1.2M ﹤0.01% 1690
2023
Q1
$1.22M Buy
+288,700
New +$3.43M 0.05% 530
2022
Q2
Sell
-10,200
Closed -$62K 1584
2022
Q1
$62K Sell
10,200
-35,200
-78% -$259K ﹤0.01% 1455
2021
Q4
$416K Buy
+45,400
New +$482K 0.03% 737
2021
Q2
Sell
-52,651
Closed -$744K 1054
2021
Q1
$744K Buy
52,651
+15,951
+43% +$258K 0.07% 301
2020
Q4
$414K Sell
36,700
-19,900
-35% -$234K 0.07% 452
2020
Q3
$747K Buy
+56,600
New +$1.13M 0.15% 212

Other funds holding ALT

Jump Financial's ALT Position: Q1 2026 in Review

Jump Financial sold out of Altimmune (ALT) in Q1 2026, closing a stake of 242,017 shares — an estimated $874K sold.

Jump Financial first reported a position in ALT in Q3 2020 and held it in 12 quarters. The position peaked at $1.87M in Q2 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Jump Financial reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 242,017 Altimmune shares in Q1 2026, an estimated $874K.
  • Jump Financial first reported a position in Altimmune in Q3 2020 and held it in 12 quarters.
  • Jump Financial's Altimmune position peaked at $1.87M in Q2 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.